Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Angioseal

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 4 (1)

Trial Status

Completed1
Withdrawn1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05899478Not ApplicableCompletedPrimary

Suture-mediated Closure System Following Endovascular Peripheral Arterial Procedures

NCT05334095Not ApplicableUnknown

Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease

NCT00590356Phase 4WithdrawnPrimary

Star-Close Versus Angio-Seal for Femoral Artery Hemostasis

Showing all 3 trials

Research Network

Common Treatments

  • Angioseal1
  • Perclose Proglide1
  • Angioseal Vip1
  • Starclose1
  • Tyknot Suturemediated Closure System1

Active Sponsors

  • Seung-Jung Park1
  • Suzhou Hengruihongyuan Medical Technology Co. LTD1
  • CardioVascular Research Foundation, Korea1
  • Xiongjing Jiang1

Top Investigators

Related Conditions

  • Peripheral Vascular Diseases1

Activity Timeline